Form 13-F position report

IDEAYA BIOSCIENCES INC

Reported by Pictet Asset Management Holding SA

IDYA CUSIP 45166A102 Manager CIK 0001993888

Reported 1,587,499 shares, up 314,653 (24.7%) from the prior quarter.

Reported value -0.2%; share count 24.7% vs. the prior quarter.

Added
% of reported 13F value 0.06% This manager · Q2 2024
Shares 1,587,499 Quarter-end amount reported
Reported value $55,737,090 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 31159078
2024-03-31 55852482
2024-06-30 55737090
2024-09-30 60012691
2024-12-31 49890665
2025-03-31 30118954
2025-06-30 37943959
2025-09-30 28107903
2025-12-31 25385961
2026-03-31 23853988
2026-06-30 26561360

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for IDEAYA BIOSCIENCES INC held by Pictet Asset Management Holding SA.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 712,674 -3,232 (-0.5%) 0.03% $26,561,360 2026-07-30
Q1 2026 Reduced 715,906 -18,429 (-2.5%) 0.03% $23,853,988 2026-04-22
Q4 2025 Reduced 734,335 -298,664 (-28.9%) 0.02% $25,385,961 2026-01-29
Q3 2025 Reduced 1,032,999 -772,137 (-42.8%) 0.03% $28,107,903 2025-11-18
Q2 2025 Reduced 1,805,136 -33,628 (-1.8%) 0.04% $37,943,959 2025-08-13
Q1 2025 Reduced 1,838,764 -102,507 (-5.3%) 0.03% $30,118,954 2025-05-05
Q4 2024 Added 1,941,271 +46,931 (2.5%) 0.05% $49,890,665 2025-02-12
Q3 2024 Added 1,894,340 +306,841 (19.3%) 0.07% $60,012,691 2024-11-12
Q2 2024 Added 1,587,499 +314,653 (24.7%) 0.06% $55,737,090 2024-08-13
Q1 2024 Added 1,272,846 +397,099 (45.3%) 0.06% $55,852,482 2024-05-14
Q4 2023 New 875,747 +875,747 (0.0%) 0.03% $31,159,078 2024-02-13

Who else reported the position

232 managers reported IDEAYA BIOSCIENCES INC for Q2 2024.

Managers reporting IDEAYA BIOSCIENCES INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 11,270,083 +1,114,829 0.03% $395,692,626 14 qtrs
BlackRock Inc Added 6,807,790 +842,377 < 0.01% $239,021,508 21 qtrs
FEDERATED HERMES INC Reduced 4,855,790 -288 0.4% $170,486,787 16 qtrs
VANGUARD GROUP INC Added 4,266,773 +111,016 < 0.01% $149,806,400 21 qtrs
JANUS HENDERSON GROUP PLC Added 4,076,020 +267,570 0.08% $143,104,277 12 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 3,743,741 -308,759 0.02% $131,444,000 15 qtrs
STATE STREET CORPORATION Reduced 2,874,296 -289,658 < 0.01% $100,916,533 17 qtrs
Boxer Capital LLC Unchanged 2,202,812 0 4.07% $77,340,729 21 qtrs
Capital Research Global Investors Added 2,164,551 +187,681 0.02% $75,997,386 5 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Reduced 2,097,113 -533,179 1.23% $73,629,637 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 13, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,553,302
Shared
0
None
34,197

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.